Recommended Lazomis QI Resources
Published Lazomis QI articles relevant to delirium screening audit and improvement work.
- Patient SafetyGuide
Diagnostic Delay: Understanding and Mitigating a Critical Patient Safety Risk
Missed or delayed recognition of delirium can lead to avoidable harm, delayed treatment of underlying causes, increased falls risk, prolonged admission and poor communication of cognitive change.
- Patient SafetyGuide
Designing Safer Clinical Processes: A Guide for Healthcare Teams
Delirium screening depends on safe clinical processes: identifying eligible patients, completing validated screening, recognising acute confusion, documenting findings, escalating concerns and reassessing on change.
- Patient SafetyGuide
Achieving Reliability in Healthcare Systems: A Practical Guide
Supports thinking about consistent screening and escalation as a reliability problem across admission, ward assessment, frailty review, nursing documentation, medical review and handover.
- Quality ImprovementGuide
PDSA Cycles: A Practical Guide to Testing Change in Healthcare
Helps translate delirium screening audit findings into practical improvement cycles such as admission-screening prompts, 4AT workflows, handover prompts or EPR alerts.
Audit-specific guidance and standards
Authoritative national guidance and local policy for delirium screening audit work.
- NICE CG103 — Delirium: prevention, diagnosis and management
- NICE QS63 — Delirium in adults
- SIGN 157 — Risk reduction and management of delirium
- British Geriatrics Society — Delirium guidance
- 4AT — Rapid clinical test for delirium (4at-test.com)
- Local delirium screening policy and validated screening tool (4AT/CAM) guidance
- Local frailty, dementia and cognitive impairment pathways
- Local falls prevention and escalation policies for acute confusion or deterioration
- Local EPR or nursing assessment documentation policy
This tool supports, but does not replace, clinical judgement. Local policy, formulary and specialist advice should be followed.